Insmed | INSM - Biaya Operasional





Biaya Operasional Perubahan Tanggal
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Cytokinetics USD 214.64M 6.85M 2026-09
DBV Technologies USD 64.8M 16.9M 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 606.26M 79.46M 2026-09
Novartis USD 13.19B 3.9B 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09